Innate Pharma (XPAR:IPH) Pre-Tax Income : €-34.05 Mil (TTM As of Jun. 2024)

Innate Pharma Pre-Tax Income Chart

Innate Pharma Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Pre-Tax Income		Get a 7-Day Free Trial					7.87	-0.83	-45.48	-57.97	-7.57

Innate Pharma Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Pre-Tax Income	Get a 7-Day Free Trial															6.38	-64.35	1.72	-9.29	-24.76

Competitive Comparison of Innate Pharma's Pre-Tax Income

For the Biotechnology subindustry, Innate Pharma's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innate Pharma's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Innate Pharma's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Innate Pharma's Pre-Tax Income falls into.

Innate Pharma Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Innate Pharma's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Innate Pharma's Pretax Income for the quarter that ended in Jun. 2024 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-34.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innate Pharma  (XPAR:IPH) Pre-Tax Income Explanation

Innate Pharma's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

During the past 13 years, Innate Pharma's highest Pretax Margin was 23.04%. The lowest was -2166.15%. And the median was -26.02%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innate Pharma Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Innate Pharma's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Innate Pharma Business Description